Clinical trial
Protect the Head to Head: A Safety and Efficacy Assessment of the Emboliner Embolic Protection Device
NCT05684146 is registered in ClinicalTrials.gov with Emboline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Protect the Head to Head: A Safety and Efficacy Assessment of the Emboliner Embolic Protection Device
- Lead sponsor
- Emboline
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 4, 2023
- Completion date
- December 31, 2024
- Enrollment
- 540 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.